Sharpe et al Supplementary Tables April 2022.docx (49.58 kB)

Using Analogue Data to Substantiate Long Term Durability of Gene Therapies: A Narrative Review. Supplementary Table - Biological Pathway Considerations.

dataset

posted on 2022-07-11, 08:02 authored by Panos Kefalas, Laura Beswick, Michaela Sharpe

Supplementary Table 1 Biological Pathway Considerations

History

Usage metrics

Categories

Regenerative medicine (incl. stem cells)

Keywords

Long-Term Outcomes Health Technology Assessment Biological Plausibility Durability of Response Gene Therapies Analogues

Licence

CC BY-NC-ND 4.0

Exports